State-of-the-Art Technology of Model Organisms for Current Human Medicine

Diagnostics
Masamitsu KonnoHideshi Ishii

Abstract

Since the 1980s, molecular biology has been used to investigate medical field mechanisms that still require the use of crude biological materials in order to achieve their necessary goals. Transcription factor-induced pluripotent stem cells are used in regenerative medicine to screen drugs and to support lost tissues. However, these cells insufficiently reconstruct whole organs and require various intact cells, such as damaged livers and diabetic pancreases. For efficient gene transfer in medical use, virally mediated gene transfers are used, although immunogenic issues are investigated. To obtain efficient detective and diagnostic power in intractable diseases, biological tools such as roundworms and zebrafish have been found to be useful for high-throughput screening (HST) and diagnosis. Taken together, this biological approach will help to fill the gaps between medical needs and novel innovations in the field of medicine.

References

Nov 1, 1983·The Journal of Experimental Zoology·C L Markert
Jul 27, 2002·Annual Review of Genomics and Human Genetics·Valerie Reinke, Kevin P White
May 20, 2003·Nature Biotechnology·Yunhong ZanMichael N Gould
Feb 26, 2004·Southern Medical Journal·Daniel J BrotmanAxel C Matzdorff
Jan 28, 2006·Cell·Alejandro Sánchez Alvarado
Nov 11, 2006·Science·Erica SodergrenRita Wright
Jun 8, 2007·Nature·Keisuke OkitaShinya Yamanaka
Mar 22, 2008·Science·Yoshito HaradaHitoshi Sawada
Mar 26, 2010·Learning & Memory·Evan L Ardiel, Catharine H Rankin
Jun 8, 2011·PloS One·Daniel D Shaye, Iva Greenwald
Jun 28, 2011·Nature Reviews. Drug Discovery·David C Swinney, Jason Anthony
Feb 23, 2013·Proceedings of the National Academy of Sciences of the United States of America·Hitomi MatsunariHiromitsu Nakauchi
Aug 9, 2013·Nature·Shin-ya TakemuraDmitri B Chklovskii
Sep 10, 2013·Nature Neuroscience·Sarah G Leinwand, Sreekanth H Chalasani
Sep 12, 2015·Nature Reviews. Drug Discovery·Calum A MacRae, Randall T Peterson
Oct 21, 2016·Nature·Adam M SessionDaniel S Rokhsar
Dec 17, 2016·Nature Reviews. Drug Discovery·Yanhong ShiShinya Yamanaka
Dec 26, 2016·Drug Metabolism and Pharmacokinetics·Kazuo Takayama, Hiroyuki Mizuguchi
Jan 18, 2017·Genesis : the Journal of Genetics and Development·Zhaoying ShiYonglong Chen
Jan 27, 2017·BMC Cancer·Héctor Guerrero-FloresMauricio Salcedo
Feb 1, 2017·Current Topics in Medicinal Chemistry·Maria CarreteroMichael Petrascheck
Oct 7, 2017·Molecular Cell·Antonino MontalbanoNeville E Sanjana
May 18, 2018·Nature·Qiao Zhou, Douglas A Melton
Aug 10, 2018·Cells, Tissues, Organs·Martin Blum, Tim Ott
Aug 17, 2018·Marine Drugs·Olga Maria LageFrancisca Vicente
Sep 3, 2018·Journal of cardiology·Shigeru Miyagawa, Yoshiki Sawa
Oct 27, 2018·Nucleic Acids Research·Jim ThurmondUNKNOWN FlyBase Consortium
Feb 12, 2019·Behavioural Pharmacology·Dario Aspesi, Graziano Pinna
Feb 26, 2019·Current Pharmaceutical Design·Ranjith Kumar KankalaAi-Zheng Chen
Jun 10, 2019·Methods : a Companion to Methods in Enzymology·D Amilan JoseSrushti Gadiyaram

❮ Previous
Next ❯

Citations

Sep 26, 2020·Biomolecules·Maximilian Breuer, Shunmoogum A Patten
Nov 5, 2020·Diagnostics·Alexander S MachikhinAndrey V Potemkin

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

BMJ : British Medical Journal
Rebecca Coombes
IARC Scientific Publications
M TeradaT Sugimura
© 2022 Meta ULC. All rights reserved